New Multicomponent Forms of the Antiretroviral Nevirapine with Improved Dissolution Performance by Costa, Rogeria Nunes et al.
Subscriber access provided by MINCyT
is published by the American Chemical Society. 1155 Sixteenth Street N.W.,
Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.
Article
New multicomponent forms of the antiretroviral
Nevirapine with improved dissolution performance
Rogeria Nunes Costa, Ana Lucía Reviglio, Sana Siedler, Simone Gonçalves Cardoso,
Yamila Garro Linck, Gustavo Alberto Monti, Alexandre Magnus G. Carvalho, Jackson
Antônio Lamounier Camargos Resende, Marcelo Henrique da Cunha Chaves, Helvécio
Vinícius Antunes Rocha, Duane Choquesillo-Lazarte, Lourdes Infantes, and Silvia L. Cuffini
Cryst. Growth Des., Just Accepted Manuscript • DOI: 10.1021/acs.cgd.9b01129 • Publication Date (Web): 09 Dec 2019
Downloaded from pubs.acs.org on December 30, 2019
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.
New multicomponent forms of the antiretroviral 
Nevirapine with improved dissolution performance 
Rogeria N. Costa,†* Ana L. Reviglio, §,¥ Sana Siedler,‡ Simone G. Cardoso,‡ Yamila G. Linck, §,¥ 
Gustavo A. Monti,§,¥ Alexandre M. G. Carvalho,¶# Jackson A. L. C. Resende,†† Marcelo H. C. 
Chaves,‡‡ Helvécio V. A. Rocha,‡‡ Duane Choquesillo-Lazarte,§§ Lourdes Infantes,¶¶ Silvia L. 
Cuffini†*  
†Instituto de Ciência e Tecnologia (ICT), Universidade Federal de São Paulo (UNIFESP), 12231-
280 São José dos Campos, Brazil 
§FAMAF-Universidad Nacional de Córdoba, 5016, Córdoba, Argentina 
¥IFEG-CONICET, 5016, Córdoba, Argentina 
‡Centro de Ciências da Saúde (CCS), Universidade Federal de Santa Catarina (UFSC), 88040-
900 Florianópolis, Brazil 
¶Laboratório Nacional de Luz Síncrotron (LNLS), Centro Nacional de Pesquisa em Energia e 
Materiais (CNPEM), 13083-100 Campinas, Brazil. 
††Universidade Federal de Mato Grosso (UFMT), 78600-000 Barra do Garças, Brazil 
‡‡Laboratório de Micro e Nanotecnologia (LMN), Farmanguinhos, Fundação Oswaldo Cruz 
(FIOCRUZ), 21040-361 Rio de Janeiro, Brazil 
Page 1 of 35
ACS Paragon Plus Environment





























































§§ Laboratorio de Estudios Cristalográficos, IACT (CSIC-UGR), Avda. de las Palmeras 4, 18100 
Armilla, Granada, Spain 
¶¶Instituto de Química Física Rocasolano (IQFR), Consejo Superior de Investigaciones 
Científicas (CSIC), 28006 Madrid, Spain 
*Corresponding authors: rogeria.ncosta@gmail.com; scuffini@unifesp.com 
KEYWORDS: Nevirapine, Cocrystals, Eutectics, Dissolution improvement 
ABSTRACT: In the pharmaceutical area, some drugs exhibit physicochemical properties that 
adversely affect the formulation processes to bioavailability and its effectiveness. Nevirapine 
(NVP) is an antiretroviral drug that presents low aqueous solubility, which impacts directly in its 
bioavailability. Among all possible modifications, multicomponent crystals, such as cocrystals 
and eutectic compositions, have been successfully used to improve the solubility of drugs. In this 
work, the propensity of the formation of multicomponent systems of NVP with seven possible 
co-formers were predicted and tested: salicylic acid (SA), 3-hydroxybenzoic acid (3HBZC), 4-
hydroxybenzoic acid (4HBZC), saccharin (SAC), theophylline (THEO), caffeine (CAF), and 
urea (URE). Results indicate that NVP-SA, NVP-SAC, NVP-3HBZC, and NVP-4HBZC are 
cocrystals, whereas NVP-THEO and NVP-CAF are eutectic materials, and NVP-URE is a solid 
physical mixture. A temperature-dependent disorder behavior was identified for NVP-SA 
cocrystal. Dissolution studies for the eutectic materials are reported, evidencing that these 
materials exhibit a significant increase in NVP dissolution kinetics. 
 
INTRODUCTION:  
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e][1,4]diazepin-6-one)1,2 is an antiretroviral drug used for treatment of AIDS/HIV-1 infection. 
According to the Biopharmaceutics Classification System (BCS), NVP is classified as a Class II 
drug, i.e., it presents low water-solubility and high permeability in the gastrointestinal tract.3 The 
low water-solubility is a challenge during the formulation of the drug directly affecting its 
bioavailability. High doses are often necessary to guarantee its effectiveness increasing possible 
adverse side effects. 
Crystallization methods can be used to obtain different crystal forms of NVP in order to 
improve its dissolution and, consequently, its bioavailability. Cocrystals and eutectics are among 
possible crystalline modifications that can be used in order to improve the physicochemical and 
pharmaceutical properties of drugs.4–10 Cocrystals have been successfully used in the 
pharmaceutical area in order to produce solid forms of a drug with improved properties.11–16 
Caira and co-workers reported the crystal structure of several NVP cocrystals with improving 
dissolution rates compared to pure NVP crystals.17 So far, eutectic systems with NVP have not 
been described in the literature. However, for other drugs, pharmaceutical eutectic systems have 
shown an accomplishment in the production of solid forms with improved properties, including 
dissolution.8,18–20 
Pharmaceutical cocrystals are formed with neutral molecules of an active pharmaceutical 
ingredient (API) and any other neutral molecule in a well-established stoichiometry.21,22 
Cocrystals are single-phase compounds, exhibiting a new crystalline structure, which is different 
from that of parent components. Further, this new phase exhibits its own physicochemical 
properties, also different from the properties exhibited by parent components (Figure 1). In turn, 
physical mixtures and eutectic systems can be described as multiphase compounds. They exhibit 
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a mixture of two or more phases that do not interact to form a new structure, such as in cocrystals 
(Figure 1). Physical mixtures exhibit the physicochemical properties of both parent compounds. 
However, at certain ratios, the eutectic mixture exhibits a lower melting point than the parent 
compounds and may also show differences in other physicochemical properties.10 Eutectic 
system formation occurs when the components are miscible in a liquid state and immiscible in 
solid-state.23 When two components, A and B, in the liquid phase are cooled, occurs the 
solidification of both components and formation of a mixture of solid phases, α and β. It can be 
concluded that an eutectic material has been obtained when it presents a single melting point 
which is dependent on the composition of the eutectic. 
 
Figure 1. Representation of the structural organization in multicomponent solid forms of an API. 
In order to produce multicomponent materials of NVP presenting better properties, a screening 
study was herein performed. The co-former molecules were selected based on the presence of 
carboxyl and amide groups that could disrupt the amide-amide dimer motif observed in the pure 
NVP structure, and that had delocalized planar structures that could stack with the pyridine 
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fragments in NVP molecules. Thus, seven co-formers, salicylic acid (SA) and its two isomers – 
3-hydroxybenzoic acid (3HBZC), 4-hydroxybenzoic acid (4HBZC) – saccharin (SAC), caffeine 
(CAF), theophylline (THEO), and urea (URE) (Scheme 1), were selected and were used in this 
screening of multi-component forms of NVP. These materials were prepared through the liquid-
assisted grinding (LAG) method, which is well-accepted for pharmaceutical cocrystal 
screening.24 Solid-state characterization was performed through single-crystal and powder X-ray 
diffraction with conventional and synchrotron radiation at different temperatures, differential 
scanning calorimetry, and solid-state nuclear magnetic resonance.  
Crystal structure of NVP-Salicylic acid and NVP-Saccharin cocrystals have been previously 
described by Caira and co-workers17 and they were selected for reproducibility purpose and to 
compare with the 3HBZC and 4HBZC isomers behavior. Besides, a full characterization for both 
multi-components, NVP-SA and NVP-SAC, has been done. NVP-SA crystals showed to present 
a temperature-dependent disorder. NVP-Urea and NVP-4-Hydroxybenzoic acid have been 
described by Nalte and co-workers.25 However, they have tested the cocrystal formation of these 
multi-component forms only through melting point determination using an open capillary tube 
method. NVP-(3HBZC, 4HBZC, THEO, CAF, URE) multicomponent crystals structures were 
not found at the CSD database. 
 
Scheme 1. Bidimensional representation for the seven co-formers used in the cocrystal screening.  
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 EXPERIMENTAL SECTION: 
Cocrystallization prediction: In order to predict the propensity formation of NVP cocrystals, 
two CCDC (Cambridge Crystallographic Data Centre) tools were used: the screening by 
molecular complementarity (MC)26 and the hydrogen-bond propensity (HBP).27 Both tools are 
available at CSD Mercury software version 4.0.0.  
The MC is a tool developed and validated by L. Fábián which output is a simple pass or fail 
answer to the formation of the cocrystals. This is based on the premise that molecules tend to 
crystallize together only if they have similar molecular properties. Therefore, a few shape and 
polarity descriptors are calculated for the API and the co-former, and to pass the MC test, they 
have to differ by less than a threshold value that Fábián established from a statistical analysis 
performed at the CSD. 
The HBP tool was originally developed as a knowledge-based method to assess the risk of 
polymorphism for a given compound, though it can also be used to evaluate cocrystal formation. 
Based on an automated statistical analysis of hydrogen bonding patterns, the HBP method 
determines interaction likelihoods for all the possible hydrogen-bonding interactions that can be 
formed with the set of functional groups present in the specific chemical environment analyzed. 
We have built three different mol2 files to analyze the seven cocrystal systems, one for each 
component (NVP and co-former) and another file containing both together. In this way, we can 
judge how likely a cocrystal is to form (Multicomponent Score) as the difference of the most 
likely interaction in pure NVP or in pure co-former and, the most likely cocrystal interaction. 
The HBP fitting data was generated using the truncate data generation mode. 
Sample preparation: The liquid-assisted grinding method was used to prepare the 
multicomponent materials containing NVP.  Seven different co-formers were tested: salicylic 
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acid (SA), 3-hydroxybenzoic acid (3HBZC), 4-hydroxybenzoic acid (4HBZC), saccharin (SAC), 
caffeine (CAF), theophylline (THEO), and urea (URE). Experimental details are available at SI. 
Powder samples were characterized by solid-state analytical techniques. 
Powder X-ray diffraction (PXRD): Pure NVP and seven pure co-formers were characterized 
by PXRD, which were carried out by using conventional (PXRD) and synchrotron (SPXRD) 
sources.  
PXRD analyses were carried out in Rigaku automatic X-ray diffractometer for powder 
diffraction (Ultima IV) by using Cu-Kα radiation source (λ = 1.5418 Å). The Kβ radiation was 
filtered. Data were recorded at tube voltage 40 kV and the current 30 mA. Samples were placed 
on Bragg-Brentano (flat plate) geometry.28,29 The D/Tex Ultra detector operated at 2θ/θ mode in 
continuous scanning at scanning rate 20 o/minute. Experiments were performed at room 
temperature, at step-size 0.01o in the angular range 5 to 35o 2θ.  
SPXRD experiments were performed at the XRD1 beamline at the Brazilian Synchrotron Light 
Laboratory (LNLS, Campinas, Brazil).30 This beamline is dedicated to X-ray powder diffraction 
analysis. It is composed of the 3-circle heavy-duty diffractometer (Newport®) and the MYTHEN 
24K detector system (Dectris®). Experiments were conducted in Debye-Scherrer geometry. 
Samples were placed in borosilicate capillaries (0.7 mm diameter). Experiments were conducted 
at 8 keV radiation and data were collected at the range 300 K to 108 K. Samples were cooled 
down using CryojetHT from OXFORD Instruments, at a cooling rate of 2 K.min-1. Equipment 
configuration allowed collecting one diffraction pattern every 1.2 K. Radiation wavelength was 
set based on Silicon standard (NIST SRM640D) data, which were collected at the end of each 
experiment. 
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Single-crystal X-Ray diffraction (SXRD): SXRD experiments for NVP-SA were performed 
in a Bruker D8 Venture diffractometer (Photon 100 CMOS detector and MoKα radiation from 
Incoatec micro source) and for NVP-4HBZC in a Bruker D8 Venture diffractometer equipped 
with a CMOS Photon 100 detector using CuKα radiation. The diffraction images were analyzed 
(indexed, integrated and scaled) in the Apex3 software.31 Crystal structures were solved through 
the direct methods and refined by Full-matrix-block least-squares in the SHELX-15 software.32 
All non-hydrogen atoms were anisotropically refined, and all hydrogen atoms were placed in 
idealized geometries according to the riding model. Connectivity restraints and rigid body were 
used to describe salicylic acid molecule disorder at room temperature. 
Differential Scanning Calorimetry (DSC): DSC curves were obtained in DSC 204 F1 
Phoenix® NETZSCH calorimeter. In order to characterize the multicomponent materials, 5 mg of 
each sample was placed in a hermetically sealed aluminum crucible and scanned at a temperature 
range of 50 ºC to 300 ºC, using a heating rate of 10 ºC.min-1. For the construction of phase-
diagrams, different compositions of eutectic systems were scanned at a temperature range of 50 
ºC to 300 ºC, using a heating rate of 3 ºC.min-1. All samples were scanned in a nitrogen air 
atmosphere (70 mL.min-1) and an empty and sealed aluminum crucible was used as a reference. 
The equipment was calibrated by using indium (m.p. 156.6 ºC and Hm 28,54 J.g-1) and zinc 
(m.p. 419.6 ºC). Data were processed in the NETZSCH Proteus® software. 
Solid-state NMR: 13C CP/MAS ssNMR studies were performed using ramp CP/MAS pulse 
sequence33,34 with proton decoupling during acquisition at room temperature. All experiments 
were carried out in a Bruker Avance II spectrometer operating at a resonance frequency of 
300.13 MHz for protons and 75.46 MHz for carbons. The spectrometer was equipped with a 4 
mm MAS probe. The spinning rate was set at 10 kHz, the recycling delay was 350 s, and the 
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contact time during CP was 2 ms. To obtain an adequate signal-to-noise ratio, 64 to 192 
transients were collected. The SPINAL-6435 pulse sequence was used for heteronuclear 
decoupling during acquisition (40.96 ms) satisfying proton field H1H ω1H/2π = γH H1H/2π = 
65.8 kHz. Glycine was used as an external reference (δCOOH=176.46 ppm) and to set the 
Hartman-Hahn condition in CP/MAS experiments. Quaternary carbon edition spectra of all 
samples were recorded through nonquaternary suppression (NQS) sequence; the 1H and 13C 
radiofrequency (rf) fields are removed during 40 μs after CP and before the acquisition. Such 
delay allows carbon magnetization to decay because of 1H–13C dipolar coupling, which results in 
spectra wherein CH and CH2 are substantially removed.
36  
Dissolution profile: Dissolution profiles were determined for NVP-THEO, NVP-CAF, and 
NVP raw material. The dissolution profiles were obtained in a Distek dissolution system 
Evolution 6100. It was used a USP apparatus II under stirring at 50 rpm. Experiments were 
carried in two different dissolution media: water and HCl 0.1 N. A volume of 900 ml of the 
medium was placed in a vessel and maintained at 37 ± 0.5 °C during all experiments. For each 
sample, 200 mg of sample was dispersed in the medium. Experiments were performed in 
triplicate. An Opt-Diss 405 system (Distek), a multi-channel, fiber optic-based UV spectrometer 
system, was attached to the dissolution system. It enabled us to collect the absorbance values and 
automatically calculated the percentage of dissolved material in each vessel. The system was set 
up to collect data every 30 seconds in the first 15 minutes, every 60 seconds in the following 45 
minutes and every 10 minutes in the second hour.  
Intrinsic dissolution rate: Intrinsic dissolution rate was calculated for NVP-THEO, NVP-
CAF, and NVP raw material. A mass of 100 mg of each sample was placed into the 0.8 cm 
diameter cavity in the apparatus. The powder was compressed under a pressure of 1600 psi for 
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60 seconds. The apparatus containing the compressed pellet was placed in 900 ml of medium. 
Two different media were used: water and HCl 0.1 N. Previous experiments were performed to 
confirm that no phase transition occurred under pressure nor in the different media.  
RESULTS AND DISCUSSION:  
A liquid-assisted grinding method with NVP and seven different co-formers (salicylic acid 
(SA), 3-hydroxybenzoic acid (3HBZC), 4-hydroxybenzoic acid (4HBZC), saccharin (SAC), 
caffeine (CAF), theophylline (THEO), and urea (URE)) were tested to obtain multicomponent 
materials. Four cocrystals confirmed by powder X-ray diffraction were obtained, NVP-SA, 
NVP-3HBZC, NVP-4HBZC, and NVP-SAC. Two eutectic materials, NVP-CAF and NVP-
THEO, were confirmed and characterized through solid-state analytical techniques. The 
remaining one, NVP-URE, resulted to be a solid physical mixture.  The dissolution properties of 
the eutectic materials were investigated.  
Cocrystallization prediction was performed using CCDC tools.  
The molecular complementarity screening (MC) for the NVP API and the seven co-formers 
has been calculated (Table 1 and Table S1). Detailed information for all calculated descriptor 
values is in Table S2. The results indicate that most of the selected co-formers are likely to form 
NVP cocrystals. Urea is not being expected to crystallize with NVP molecules. This is due to the 
fact that the urea molecule has a fraction of N and O atoms overall non-hydrogen-atoms present 
in the molecule, three times higher than NVP. While if SA is selected as co-former the 
propensity to crystallize with NVP depends on the SA conformer used from the CSD. 
Furthermore, the small (S) axis of the imaginary calculated rectangular box that enclosed the 
URE molecule (MC method uses this box to define the shape and size descriptors) is much 
shorter than that calculated for NVP. None of these two descriptors pass the permitted MC 
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threshold (Table S2). For SA molecule the difference in S axis with NVP is close to the threshold 
and a slight rotation of the hydrogens in the molecule, modify the length in the S axis leading to 
pass or fail the MC test. 




Salicylic acid, SA PASS/FAIL 
3-Hydroxybenzoic acid, 3HBZC PASS 
4-Hydroxybenzoic acid, 4HBZC PASS 
Saccharin, SAC PASS 
Caffeine, CAF PASS 
Theophylline, THE PASS 
Urea, URE FAIL 
 
 
The HBP analysis is available for polymorph assessment for one single molecule. Here, we 
have calculated HBP to assess the propensity of H-bonding in a multicomponent formation, AB, 
where A is the NVP and B is the co-former. All hydrogen-bond donor and acceptor atoms of 
both molecules are considered. The propensity is calculated for all donoracceptor interactions 
between A-A, B-B, A-B, and B-A. It was considered the maximum propensity in each case 
(Table 2). A multi-component score was calculated through the difference of the maximum 
propensity for hetero-interactions, A-B or B-A, which are probabilities (from 0 to 1) of each 
possible H-bonds, and the maximum propensity for H-bond homo-interactions, A-A or B-B. 
Thus, a positive and higher multi-component score means a greater propensity to form hetero-
interactions, and consequently, a higher probability to obtain multi-component structures. 
Considering the nature of cocrystal and eutectic structures, hetero-interactions are observed in 
cocrystals and in the inter-domain surface in eutectics; therefore, high positive multi-component 
scores must be related to cocrystal prediction. We should note that organic eutectics are 
Page 11 of 35
ACS Paragon Plus Environment





























































conglomerates of lattice structures of the components where only in the inter-phase between 
domains appears hetero-interactions. 
 












Salicylic acid, SA B:A 0.69 0.52 0.33 0.17 
3-Hydroxybenzoic acid, 3HBZC B:A 0.69 0.52 0.34 0.17 
4-Hydroxybenzoic acid, 4HBZC B:A 0.70 0.53 0.34 0.17 
Theophylline, THE  B:A 0.63 0.44 0.56 0.07 
Urea, URE  B:B 0.94 0.45 0.95 -0.01 
Saccharin, SAC  B:B 0.50 0.42 0.57 -0.07 
Caffeine, CAF  A:A 0.25 0.41 -- -0.16 
 
 
The multi-component scores obtained for the NVP cocrystals with the seven co-formers are 
shown in Table 2 using a traffic light analogy. SA, 3HBZC, and 4HBZC, in green, are the most 
likely molecules to form NVP multicomponent solids. It agrees with our experimental results. 
On the other side, CAF exhibits the highest negative score. This molecule does not have any H-
bond donors, which affects the propensity results. Finally, SAC, THEO, and URE, in yellow, 
exhibit intermediate multi-component score values. Only one-phase multi-component materials 
should be predicted by the HBP tool for SAC, THEO, and URE because only in these solids H-
bond interactions between the components are expected.  
Powder X-ray Diffraction (PXRD) analysis was carried out in order to identify the 
crystalline phases obtained after sample preparation. Diffraction patterns of all prepared samples 
were compared to diffraction patterns of its parental compounds. PXRD results indicate that 
NVP-SA, NVP-3HBZC, NVP-4HBZC, and NVP-SAC samples correspond to new phases, 
whereas NVP-THEO, NVP-CAF, and NVP-URE are a mixture of NVP and co-former phases 
(Figure S1). Furthermore, NVP-SA and NVP-SAC PXRD data were also compared to structures 
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reported at the CSD. Comparing NVP-SAC with the reported structure (CSD refcode: 
LATQOO)17, one can conclude that we have obtained the same crystallographic phase recorded 
by Caira et al. (Figure S2). However, a comparison of NVP-SA and the reported cocrystal (CSD 
refcode: LATQUU)17 evidence some differences. It is important to mention that PXRD data were 
collected at room temperature (RT) and Caira´s reported structure was determined at low 
temperature (100 K).17 Significant differences were observed at approximately 12.5o and in the 
region between 15o and 20o which could be evidence of structural changes with the temperature 
(Figure S3). Further characterization was performed in order to understand these differences in 
the diffraction patterns and the results will be presented later. 
Solid-state NMR analysis was carried out in NVP-SA, NVP-SAC, NVP-THEO, NVP-CAF, 
and NVP-URE samples. The 13C CP/MAS spectra of NVP and SA are shown in Figure 2. The 
carbon assignments and chemical shift values in all spectra are given in Table S3. The 
assignments were done considering the NQS spectra. The 13C CP/MAS spectrum did not show 
multiplicity in the resonance lines in both cases, thus indicating only one molecule per 
asymmetric unit. The 13C CP/MAS spectrum of NVP-SA is also shown in Figure 2. Clear 
changes in the chemical shifts of signals can be found by comparing NVP-SA with the co-
formers. Thus, it is possible to assure the existence of an interaction between NVP and SA.  
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Figure 2. 13C CP/MAS Spectra of NVP-SA, SA, and NVP. Carbon numbering adopted 
throughout the study is highlighted. 
The 13C CP/MAS spectra of the NVP-SAC sample exhibit changes in the chemical shift of the 
signals regarding the spectra of the precursors. This is an indication of modifications in the 
environments of both molecules and the presence of interactions between them (Figure S4). On 
the other hand, the ssNMR 13C spectra for NVP-THEO, NVP-CAF, and NVP-URE are the 
addition of the spectra of NVP and the respective co-former (Figure S4). This result evidence 
that there is no interaction between the pure compounds, i.e. the result of the cocrystallization 
process is the physical mixture of the precursors. These results agree with that obtained by 
PXRD.  
Differential Scanning Calorimetry (DSC) analysis was carried out in all multi-component 
samples. As expected, NVP-SA, NVP-3HBZC, NVP-4HBZC, and NVP-SAC cocrystals were 
also confirmed through DSC. Although Nalte and co-workers25 have described NVP-URE as a 
cocrystal, with a different melting point, the DSC results indicate that this sample consists of a 
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physical mixture. In the cases of NVP-THEO and NVP-CAF, interesting thermal behavior was 
noticed and are commented on in the sequence. All curves are available at SI (Figure S5).  
According to PXRD and ssNMR analysis, one can conclude that the NVP-THEO and NVP-
CAF are simply physical mixtures of NVP and co-former. However, DSC results showed that 
NVP-THEO and NVP-CAF behavior is not that expected for physical mixtures. In the case of 
the NVP-THEO, the multi-component system presented two thermal events at 223.6 ºC and 
234.1 ºC; however, NVP melts at 247.8 ºC, whereas THEO melts at 274.7 ºC. Since the mixture 
melts in a temperature below the melting point of the pure compounds, the data exhibited for 
NVP-THEO would allow thinking that this could be a eutectic system. NVP-CAF presented a 
similar behavior. The DSC analysis for the NVP-CAF sample showed thermal events at 163.1 
°C, 204.4 ºC, and 212.8 ºC. The pure CAF presented two main events at 155.8 ºC and 238.6 °C. 
The first point was consistent with data in the literature, which indicates a phase transition for 
caffeine at 153 ºC,37 whereas the second event corresponds to the melting point of CAF. Thus, 
the event occurring at 163.1 ºC is corresponding to the phase transition of CAF; however, the 
following two events are not related to pure CAF or to pure NVP. Adding this evidence to PXRD 
and ssNMR results, one can conclude that NVP-CAF could also be a eutectic system. 
In order to investigate the eutectic systems, different compositions of NVP-THEO and NVP-
CAF were analyzed through DSC. Eleven curves were obtained for each system (Figure S6), 
corresponding to pure NVP, pure co-former (THEO or CAF), and samples at ratios of 1:9, 2:8, 
3:7, 4:6, 5:5, 6:4, 7:3, 8:2, and 9:1 (m/m). Samples were prepared by a simple mixture of 
components in the absence of solvent. Both systems, NVP-THEO and NVP-CAF, present similar 
behaviors. For each set of a mixture, there is a curve where only one event appears and it 
corresponds to the eutectic composition of the system. In all the other curves, there is an event 
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corresponding to the melt of the eutectic, followed by a second event. This second event 
corresponds to the excess of NVP or co-former, which has a variable melting point according to 
the composition. In the case of NVP-THEO, the eutectic composition occurs in a ratio of 7:3 
(m/m), presenting an eutectic temperature of 224.1 ºC approximately. In the ratios of 8:2 and 9:1, 
the second event corresponds to the melting of NVP, whereas in the ratios of 1:9, 2:8, 3:7, 4:6, 
5:5, and 6:4, it corresponds to the melting point of THEO (Figure S6a). For the NVP-CAF 
system, the eutectic composition occurs in a ratio of 3:7 (m/m), with a eutectic temperature of 
203.4 ºC approximately. In ratios of 1:9 and 2:8, the second event corresponds to the melting 
point of CAF, whereas in the ratios of 4:6, 5:5, 6:4, 7:3, 8:2, and 9:1 it corresponds to NVP 
(Figure S6b).   
Based on the thermal curves obtained at different compositions, phase diagrams for both 
systems were obtained (Figure 3). In the case of NVP-THEO, one can clearly distinguish the 
liquidus and solidus lines. The solidus line corresponding to the constant curve at approximately 
222 ºC. This line marks the temperature where the eutectic mixture starts to melt, that is, the 
eutectic temperature. In the case of NVP-CAF, an eutectic temperature around ~202 ºC is present 
in all compositions, marking the solidus line for this diagram, and consequently, the eutectic 
temperature. In addition, a line around 153 ºC can be seen and is corresponding to the phase 
transition of CAF. The intersection of the liquidus lines and the solidus line in each diagram 
allows obtaining the eutectic composition in each system. Using the linear fitting, it was possible 
to determine the eutectic composition of 70:30 (% m/m) for NVP-THEO, and 36:64 (% m/m) for 
NVP-CAF. 
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Figure 3. Phase diagrams for NVP-THEO and NVP-CAF systems. The arrows indicate the 
eutectic points in each system. In the NVP-CAF phase diagram, besides the liquidus and solidus 
lines, it is also possible to see the caffeine phase transition (black dots). 
 
Single Crystal X-ray Diffraction: In order to determine the crystalline structure of the four 
cocrystals obtained, slow evaporation experiments were carried out for all of them attempting to 
obtain good single-crystals for SCXRD experiments. Although single crystals were obtained for 
NVP-SA and NVP-4HBZC, so far it has not been possible to grow crystals of suitable quality to 
carry out SCXRD experiments for NVP-SAC and NVP-3HBZC. Crystallographic parameters are 
summarized in Table S4. Structures of the NVP-SA multicomponent at room temperature (RT) 
and 100 K (LT) present the same Space Group, P-1; however, the second has twice volume than 
the first; and while the NVP-SA at RT has z’ equal to 1, the LT structure has z’ equal to 2. Both 
present a stoichiometry NVP co-former 2:1. Salicylic acid molecules at RT are positioned in a 
center of symmetry that confer disorder to them (Figure 4). The precession images (Figure S7) 
verify the confidence of the assigned unit cell in both cases, since the unit cell at room 
temperature could not explain all the observed reflections in the experiment at low temperature, 
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and corroborate the loss of the inversion center of symmetry at the NVP dimer and over the 
Salicylic acid molecules (Figure 5 and Figure 6) which doubles the asymmetric unit and, 
therefore the unit cell volume (Table S5). NVP-4HBZC crystallizes in the C2/c monoclinic space 
group and it presents one nevirapine molecule and one 4-hydroxybenzoic acid molecule in the 
asymmetric unit (Figure 7). Nevirapine molecules in the title structures do not present significant 
differences in bond distances and angles. They display a “butterfly” conformation with angles 
between the pyridine rings at the range (119.9º – 126.4º) in agreement with pure NVP structure 
(CSD refcode: PABHIJ01)38 121.9º.  
 
 
Figure 4. Representation of NVP-SA cocrystal asymmetric unit at room temperature (inversion 
center indicated by a yellow dot and hydrogen bond interactions as dashed blue lines). Thermal 
ellipsoids drew at 50% probability level. 
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Figure 5. Comparison of the SA molecule position in the NVP-SA structures at room 
temperature (white) and at 100 K (grey).  
 
Figure 6. Representation of the NVP-SA cocrystal asymmetric unit at 100 K (hydrogen bond 
interactions depicted as dashed blue lines). Thermal ellipsoids drew at 50% probability level. 
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Figure 7. Representation of the NVP-4HBZC cocrystal asymmetric unit (hydrogen bond 
interactions depicted as dashed blue lines). Thermal ellipsoids drew at 50% probability level. 
 
Nevirapine molecules in NVP-SA structure form homodimers through amide-amide 
interactions that display a motif with graph set R2,2(8). In NVP-4HBZC a hydrogen motif with 
the same graph set R2,2(8) is also observed; but it corresponds to a hydrogen bond motif formed 
between the carboxylic acid in 4HBZC and the amide group in NVP, displaying heterodimers.  
If we compare the crystal packing that displays pure nevirapine in PAHBIJ0138 with the 
nevirapine molecules packing in the NVP-SA and NVP-4HBZC cocrystal structures, the 
observed infinite pyridine stacking ( interactions) of nevirapine molecules observed in 
PABHIJ01 is also conserved in NVP-SA and NVP-4HBZC cocrystals (Figure 8). Furthermore, if 
we consider in the strong amide-amide hydrogen bonds, these chains growth into mimic layers 
for PABHIJ01 and NVP-SA (Figure 8d). NVP-4HBZC does not present homodimers and 
therefore do not form these layers. However, the cocrystal reported by Caira et al. of NVP and 
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SAC (LATQOO)17 does also present mimic 1D infinite chains and 2D layers in its crystal 
structure. The way in which these layers are packed in the crystal is different; while in 
PABHIJ01 structure there are no holes, in NVP-SA and NVP-SAC (LATQOO) cocrystals the 
layers pack forming parallel pipes that allow the SA and SAC molecules to be located forming 
tapes (Figure 9 and Figure S8). 
 
 
Figure 8. Crystal structure of (a) pure nevirapine, PABHIJ01, (b) NVP-SA at 100K and (c) NVP-
4HBZC. Red dotted ellipses round infinite NVP chains and zigzag dashed green lines frame the 
nevirapine layers that are common into PABHIJ01 and NVP-SA packing. (d) Perpendicular 
projection of a nevirapine layer for the PABHIJ01 compound. Superposition of nevirapine chains 
for the structures: (e) PABHIJ01 (yellow) and NVP-SA (grey) (f) PABHIJ01 (yellow) and 
4HBZC (grey). 
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Justified by the fact that SA molecules are situated in pipe-shaped channels along with the 
NVP cocrystal structure, we propose a dynamic disorder at the RT structure. Salicylic acid 
molecules rotate 180º synchronously along with the crystal probably due to the low energy 
barrier between both conformations; while, SA molecules are not able to present dynamic effects 
in the crystal at 100 K. This disorder can also explain the Caira et al. structure recorded at the 
CSD with LATQUU refcode,17 which presents the same unit cell and space group as our 
structure at low temperature. Both data were collected at 100 K; however, the experiments were 
carried out in a different manner. We kept the crystal mounted at the goniometer head during the 
cooling ramp, while in LATQUU, the crystal was frozen instantly. This can obviously make a 
difference; a ramped temperature allows a conformational selection while fast freezing does not. 
In addition, rapid freezing produces a disorder in the salicylic acid molecule, showing two 
orientations: the major, presenting a final refined site occupancy factor of 0.74, coinciding with 
the observed in our LT structure; and the minor, with occupancy of 0.26, which is suggested as a 
possible “intermediate state” (Figure 9). 
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Figure 9. Structure of NVP-SA showing the pipe-shaped voids in yellow and on the right, the 
extended projection of the observed SA tapes that fit in those channels for the three discussed 
NVP-SA cocrystals. 
Powder dissolution profile and intrinsic dissolution rate (IDR) 
As the cocrystals, eutectic systems can present advantages over the pure drug. In order to 
evaluate the impact of eutectic systems in the dissolution properties, the powder dissolution 
profiles and the intrinsic dissolution rates of pure NVP, NVP-THEO and NVP-CAF in water and 
HCl 0.1N mediums were determined (Figure 10).  
In the HCl 0.1 N medium, whilst pure NVP takes more than 80 minutes to dissolve 80 % of its 
initial amount, NVP-THEO takes less than 20 minutes and NVP-CAF takes less than 5 minutes 
to dissolve the same amount. These results clearly show that the eutectics exhibit an advantage 
respect to the pure NVP relative to the dissolution kinetics. In water, this advantage is even 
greater. While less than 5% of pure NVP dissolves over 2 hours, eutectic materials reach 40% of 
dissolved material in less than 20 minutes for NVP-THEO and in less than 5 minutes for NVP-
CAF.  
Although IDR was considered a parameter relevant for the biopharmaceutical classification 
system in the past,39,40 the literature indicates that nowadays it is been more relevant as a solid-
state characterization technique.41,42 As previously described, all the samples show different 
crystal structures and, so, the intrinsic dissolution behavior was expected to be different too. All 
the samples presented R2 values higher than 0.9, showing that no transition occurred during the 
test. Moreover, just dissolution values of less than 10% were considered to plot the results. Both 
modifications, with THEO and CAF, showed IDR higher than that of the pure raw material. 
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So, both dissolution tests here proposed can be used to discriminate between the raw material 
and the prepared samples and also between these two modifications made. It can be concluded 




Figure 10. The dissolution profile of NVP in eutectic systems in comparison to pure NVP at HCl 
0.1 N and water. Intrinsic dissolution rates of NVP in the same samples were also determined for 
the same dissolution mediums. 
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In the attempt to improve the physicochemical properties of the antiretroviral nevirapine we 
have chosen seven compounds to search for NVP multi-components. They have been chosen 
because of their possible ability to alter the interactions observed in the packing arrangement of 
pure NVP due to the fact that these molecules contain carboxylic acid, amide and planar 
electron-delocalized fragments in their formula. The multicomponent samples were characterized 
through solid-state techniques and the results indicate that our initial criterium was quite right 
and 4 cocrystals (NVP-SA, NVP-SAC, NVP-3HBZC, NVP-4HBZC), 2 eutectics (NVP-THEO, 
NVP-CAF) and 1 (NVP-URE) physical mixture were identified. Moreover, we have used the 
multicomponent prediction tools available in the CSD to confirm if they can be helpful in this 
type of study. Results have shown they are adequate. Molecular complementarity (MC) tool 
establishes all co-formers as suitable to form cocrystals or multi-components with NVP except 
for urea. With the hydrogen bond propensity (HBP) tool, a high probability of obtaining 
cocrystals for SA, 3HBZC, and 4HBZC is predicted, for SAC, THEO and URE the probabilities 
are almost nil and, in the case of CAF, the results do show incompatibility to form cocrystals 
with NVP. 
Despite the methodology used to achieve the multicomponent structures is different from those 
used by Caira (reference), the same crystalline phase was obtained for NVP-SA and NVP-SAC 
as the one reported in the literature. The NVP-SA structures obtained in this work and their 
comparison with LATQUU allowed moreover to identify a temperature-dependent dynamic 
disorder behavior of the salicylic acid molecules along the channels displayed in the NVP host 
crystal. Further studies are required and they will be presented in a future manuscript. 
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NVP-THEO and NVP-CAF results comply with the formation of eutectics since two different 
phases and a single melting point were determined. In order to start understanding the behavior 
of these two systems, phase-diagrams were obtained. Also, the composition and melting point of 
these eutectics were determined. Moreover, dissolution studies have demonstrated an 
improvement in the dissolution kinetics behavior of these materials compared to pure NVP, 
especially in the aqueous medium. 
Finally, once again multicomponent materials are presented as a good strategy to improve the 
properties of pharmaceutical drugs and knowledge-based methods are useful tools for selecting 
molecules with the highest probability of crystallizing with an API. 
 
DEDICATION TO JOEL BERNSTEIN  
This paper is dedicated to Joel Bernstein, and the reason is the following. Joel was a great 
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Figure 11. Note written by Joel Bernstein due to his first visit to Latin America, Brazil and 
Argentina.  
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by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 
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Synopsis: Formation propensity and experimental studies of NVP with seven co-formers 
revealed the formation of four cocrystals, two eutectics, and one physical mixture. Eutectic 
increases significantly the solubility of pure NVP. The amide homodimer is kept in three of the 
cocrystals and is disrupted in the case of NVP-4HBZC cocrystal. Moreover, it is observed a 
temperature-dependent disorder in the NVP-SA cocrystal.  
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Formation propensity and experimental studies of NVP with seven co-formers revealed the formation of four 
cocrystals, two eutectics, and one physical mixture. Eutectic increases significantly the solubility of pure 
NVP. The amide homodimer is kept in three of the cocrystals and is disrupted in the case of NVP-4HBZC 
cocrystal. Moreover, it is observed a temperature-dependent disorder in the NVP-SA cocrystal. 
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